as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹520.6
Change
+0.45 (0.09%)
Open
₹520.15
Prev. Close
₹520.15
Day High
₹524.0
Day Low
₹513.35
Volume Analysis
Traded
60,614
Delivered
23,751
Delivery %
39.18%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Promoter holding is rising
Weaknesses (1)
- •Low return on equity (3.98%)
Opportunities (1)
- •Strong 3-year revenue growth (20.7%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹535.94 | ₹529.97 | ₹525.29 | ₹519.32 | ₹514.64 | ₹508.67 | ₹503.99 |
| Fibonacci | ₹529.97 | ₹525.9 | ₹523.39 | ₹519.32 | ₹515.25 | ₹512.74 | ₹508.67 |
| Camarilla | ₹523.53 | ₹522.55 | ₹521.58 | ₹519.32 | ₹519.62 | ₹518.65 | ₹517.67 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+12.14%
1 Week
-1.86%
1 Month
-1.13%
3 Months
-9.52%
6 Months
+19.47%
1 Year
+7.94%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹159.78
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
2.83%
Net margin 4.14% × asset turnover 0.39x × equity multiplier 1.75x
Company Overview
Sector
Fast Moving Consumer Goods
Market Cap
₹16,567 Cr
P/E (TTM)
74.8
ROE
3.98%
Book Value
₹183.0
Face Value
₹2.0
Source: Screener.in (Consolidated figures) — data as of 22 Sep 2026. Not investment advice.
TopFund Analysis
Zydus Wellness Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 56/100. The strongest factor is Corporate Governance (98/100), while Valuation (26/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising; low return on equity (3.98%). Strong 3-year revenue growth (20.7%).
TopFund Score — Fundamentals Quality
56/100 — AverageData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is expected to give good quarter
- −Stock is trading at 2.84 times its book value
- −Company has a low return on equity of 5.08% over last 3 years.
- −Company might be capitalizing the interest cost
- −Dividend payout has been low at 14.1% of profits over last 3 years
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
CMO Arijit Sengupta resigned effective September 18, 2026.
Zydus Wellness clarified no undisclosed event behind recent share volume increase.
Exchange has sought clarification from Zydus Wellness Ltd on September 8, 2026, with reference to Movement in Volume.
SES assigned Zydus Wellness ESG score 71.7, up from 70 in FY25.
Zydus Wellness will participate in Anand Rathi G-200 Anand Summit 2026 on September 22, 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 702 | 440 | 403 | 783 | 841 | 493 | 462 | 913 | 861 | 650 | 965 | 1,485 | 1,437 |
| Expenses + | 586 | 423 | 390 | 620 | 686 | 473 | 447 | 723 | 705 | 628 | 904 | 1,215 | 1,195 |
| Operating Profit | 116 | 17 | 13 | 162 | 155 | 20 | 15 | 190 | 156 | 23 | 61 | 270 | 242 |
| OPM % | 17.0% | 3.8% | 3.1% | 21.0% | 18.0% | 4.0% | 3.2% | 21.0% | 18.0% | 3.5% | 6.0% | 18.0% | 17.0% |
| Other Income + | -12 | 4 | 3 | 4 | 5 | 10 | 4 | 1 | 3 | -33 | -6 | 1 | 4 |
| Interest | 5 | 6 | 6 | 6 | 4 | 1 | 3 | 4 | 2 | 16 | 41 | 39 | 26 |
| Depreciation | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 13 | 11 | 25 | 56 | 55 | 57 |
| Profit before tax | 93 | 9 | 4 | 154 | 152 | 24 | 10 | 173 | 145 | -51 | -42 | 177 | 162 |
| Tax % | -18.0% | 31.0% | 92.0% | 3.0% | 3.0% | 12.0% | 37.0% | 1.0% | 12.0% | 4.0% | -4.0% | 9.0% | 27.0% |
| Net Profit + | 110 | 6 | 0 | 150 | 148 | 21 | 6 | 172 | 128 | -53 | -40 | 162 | 119 |
| EPS in Rs | 3 | 0 | 0 | 5 | 5 | 1 | 0 | 5 | 4 | -2 | -1 | 5 | 4 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 431 | 397 | 431 | 513 | 843 | 1,767 | 1,867 | 2,009 | 2,255 | 2,328 | 2,709 | 3,961 | 4,537 |
| Expenses + | 331 | 305 | 331 | 387 | 658 | 1,446 | 1,522 | 1,664 | 1,918 | 2,020 | 2,329 | 3,451 | 3,941 |
| Operating Profit | 100 | 91 | 99 | 125 | 185 | 321 | 344 | 345 | 337 | 308 | 380 | 510 | 596 |
| OPM % | 23.0% | 23.0% | 23.0% | 24.0% | 22.0% | 18.0% | 18.0% | 17.0% | 15.0% | 13.0% | 14.0% | 13.0% | 13.0% |
| Other Income + | 28 | 32 | 32 | 35 | 28 | -33 | -123 | 10 | -5 | 0 | 20 | -34 | -34 |
| Interest | 0 | 0 | 1 | 2 | 30 | 140 | 84 | 26 | 16 | 24 | 12 | 98 | 122 |
| Depreciation | 8 | 7 | 7 | 9 | 13 | 26 | 25 | 24 | 25 | 24 | 28 | 147 | 193 |
| Profit before tax | 120 | 117 | 124 | 150 | 171 | 121 | 112 | 306 | 291 | 260 | 359 | 230 | 247 |
| Tax % | 7.0% | 10.0% | 10.0% | 9.0% | 0.0% | -17.0% | -6.0% | -1.0% | -7.0% | -3.0% | 3.0% | 14.0% | — |
| Net Profit + | 111 | 105 | 111 | 137 | 171 | 142 | 119 | 309 | 310 | 267 | 347 | 197 | 188 |
| EPS in Rs | 6 | 5 | 6 | 7 | 6 | 5 | 4 | 10 | 10 | 8 | 11 | 6 | 6 |
| Dividend Payout % | 22.0% | 25.0% | 23.0% | 23.0% | 17.0% | 20.0% | 27.0% | 10.0% | 10.0% | 12.0% | 11.0% | 19.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 367 | 439 | 518 | 652 | 3,329 | 3,403 | 4,504 | 4,780 | 5,059 | 5,294 | 5,608 | 5,762 |
| Borrowings + | 0 | 0 | 25 | 25 | 1,569 | 1,519 | 550 | 387 | 297 | 329 | 188 | 3,203 |
| Other Liabilities + | 102 | 89 | 100 | 112 | 503 | 610 | 548 | 461 | 413 | 462 | 582 | 1,161 |
| Total Liabilities | 508 | 568 | 682 | 829 | 5,459 | 5,590 | 5,666 | 5,692 | 5,833 | 6,148 | 6,442 | 10,190 |
| Fixed Assets + | 84 | 82 | 103 | 104 | 4,567 | 4,674 | 4,667 | 4,710 | 4,732 | 4,708 | 5,125 | 8,596 |
| CWIP | 0 | 0 | 0 | 0 | 10 | 4 | 4 | 12 | 13 | 10 | 15 | 23 |
| Investments | 0 | 94 | 30 | 148 | 46 | 110 | 0 | 27 | 70 | 78 | 36 | 5 |
| Other Assets + | 423 | 391 | 550 | 577 | 835 | 802 | 995 | 943 | 1,018 | 1,354 | 1,266 | 1,566 |
| Total Assets | 508 | 568 | 682 | 829 | 5,459 | 5,590 | 5,666 | 5,692 | 5,833 | 6,148 | 6,442 | 10,190 |
| Equity Capital | 39 | 39 | 39 | 39 | 58 | 58 | 64 | 64 | 64 | 64 | 64 | 64 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 69 | 90 | 77 | 69 | 149 | 259 | 287 | 237 | 92 | 246 | 380 | 226 |
| Cash from Investing Activity + | 29 | -28 | -72 | -59 | -4,092 | -17 | -10 | -59 | -85 | -178 | -207 | -2,881 |
| Cash from Financing Activity + | -27 | -58 | -6 | -2 | 4,052 | -260 | -216 | -234 | -138 | -26 | -186 | 2,698 |
| Net Cash Flow | 71 | 4 | -1 | 8 | 109 | -18 | 60 | -56 | -132 | 43 | -13 | 44 |
| CFO/OP | 80 | 114 | 86 | 64 | 115 | 81 | 83 | 70 | 28 | 81 | 99 | 50 |
| Free Cash Flow | 72 | 86 | 46 | 61 | 132 | 235 | 269 | 162 | 47 | 220 | 315 | 126 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 7.81% | 7.91% | 7.71% | 7.65% | 6.67% | 6.89% | 7.3% | 7.83% | 8.18% | 8.51% | 8.32% | 7.92% |
| Promoters | 68.54% | 69.15% | 69.62% | 69.62% | 69.62% | 69.62% | 69.64% | 69.64% | 69.64% | 69.64% | 69.64% | 69.63% |
| FII | 3.42% | 3.25% | 3.26% | 3.29% | 3.36% | 3.37% | 3.29% | 3.25% | 3.43% | 3.27% | 3.17% | 3.32% |
| DII | 20.22% | 19.67% | 19.41% | 19.44% | 20.37% | 20.12% | 19.76% | 19.27% | 18.76% | 18.58% | 18.87% | 19.13% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Fast Moving Consumer Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Zydus Wellness Limited (this stock) | 16,567 | 74.8 | 2.85 | 3.98% |
| Emami Limited | 17,087 | 22.6 | 5.84 | 26.2% |
| Honasa Consumer Limited | 15,763 | 62.4 | 11.15 | 15.7% |
| Bikaji Foods Intern Ltd | 14,939 | 57.1 | 9.3 | 17.5% |
| Lt Foods Limited | 14,677 | 22.9 | 3.25 | 14.7% |
| Tilaknagar Industries Ltd | 14,420 | 63.8 | 4.81 | 13.1% |
| Balrampur Chini Mills Ltd | 14,258 | 38.4 | 3.29 | 9.51% |
Which Mutual Funds Hold Zydus Wellness Limited?
Frequently Asked Questions about Zydus Wellness Limited
Zydus Wellness Limited (ZYDUSWELL) closed at ₹520.6 on NSE on 25 September 2026, up 0.45 (0.09%) from the previous close.
Zydus Wellness Limited trades on the NSE (National Stock Exchange of India) under the symbol ZYDUSWELL.
Zydus Wellness Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 74.8.
Zydus Wellness Limited has a dividend yield of 0.23%.
Zydus Wellness Limited's 52-week high is ₹612.0 and its 52-week low is ₹358.0.
Zydus Wellness Limited has a market capitalisation of ₹16,567 crore.
Zydus Wellness Limited has a TopFund Quality Score of 56/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Zydus Wellness Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.